| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/02/2002 | WO2002035228A2 Method and test kit for detecting analytes in a sample |
| 05/02/2002 | WO2002035227A1 Method and apparatus for monitoring oxygen concentration in beverage production process |
| 05/02/2002 | WO2002035216A1 Multilayer analytical element and method for determination of analytes in fluids containing interfering substances |
| 05/02/2002 | WO2002035215A1 Method of detecting hydroxyproline and kit for detection |
| 05/02/2002 | WO2002035212A1 Method for the prediction of starch digestion |
| 05/02/2002 | WO2002035205A2 Process for detecting or quantifying a biological reaction using superparamagnetic label |
| 05/02/2002 | WO2002034953A2 Detection and quantification of human herpes viruses |
| 05/02/2002 | WO2002034951A2 Compositions and methods for detecting human immunodeficiency virus 2 (hiv-2) |
| 05/02/2002 | WO2002034950A2 Immobilization of biopolymers to aminated substrates by direct adsorption |
| 05/02/2002 | WO2002034945A2 Estrogen receptor alpha variants and methods of detection thereof |
| 05/02/2002 | WO2002034944A1 High precision and intellectual biochip arrayer having function of respotting |
| 05/02/2002 | WO2002034942A2 Nucleic acid amplification-based methods for the determination of a methylation profile and reagents therefor |
| 05/02/2002 | WO2002034940A2 Methods for screening compounds that modulate lipid metabolism |
| 05/02/2002 | WO2002034938A1 Diagnostics and examination method for cancer of the colon using tannase as indication |
| 05/02/2002 | WO2002034933A2 Methods and compositions for modifying biologically active target molecules |
| 05/02/2002 | WO2002034922A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/02/2002 | WO2002034919A1 Variants of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase |
| 05/02/2002 | WO2002034918A2 E. coli 0157:h7 c1 esterase inhibitor-binding protein stce and uses thereof |
| 05/02/2002 | WO2002034916A2 Novel mutant igbp-3 molecules that do not bind to igfs, but retain their ability to functionally bind igfbp-3 receptor |
| 05/02/2002 | WO2002034913A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 05/02/2002 | WO2002034911A1 Mfq-114, a human ajuba like protein |
| 05/02/2002 | WO2002034909A2 Engineered chimera of hiv protein fragments and uses thereof |
| 05/02/2002 | WO2002034899A2 Tec kinase assay |
| 05/02/2002 | WO2002034891A2 Immortalized preosteoblasts and method for their production |
| 05/02/2002 | WO2002034887A2 Maturation of dendritic cells |
| 05/02/2002 | WO2002034789A1 Monoclonal antibodies directed against hepatitis b viruses |
| 05/02/2002 | WO2002034788A1 Monoclonal antibodies to the map protein and method of use in treating or preventing infections |
| 05/02/2002 | WO2002034783A2 Transmembrane proteins |
| 05/02/2002 | WO2002034769A2 Immunoreactive peptide ctl epitopes of human cytomegalovirus pp150 |
| 05/02/2002 | WO2002034651A1 Device for preparing a sample for analysis |
| 05/02/2002 | WO2002034392A2 Vessel centering system and method |
| 05/02/2002 | WO2002034289A1 Modulating angiogenesis |
| 05/02/2002 | WO2002034280A2 Use of vanilloid 4 receptor and antagonists or agonists thereof for treating diseases associated with pain |
| 05/02/2002 | WO2002034273A1 Compositions and methods for diagnosis and treatment of cardiovascular disorders |
| 05/02/2002 | WO2002034117A2 Multiple epitopes connected by a carrier |
| 05/02/2002 | WO2002034110A2 Method of determining global coagulability and hemostatic potential |
| 05/02/2002 | WO2002034109A2 A reagent and kit for determining global coagulability and hemostatic potential |
| 05/02/2002 | WO2002019812A3 Mutant non-human mammal for expressing the alpha6 acetylcholine nicotinic receptor subunit and use for screening substances capable of interacting with said receptor |
| 05/02/2002 | WO2002018446A3 Methods of designing and producing compounds having improved binding affinity for cd154 or other trimeric proteins |
| 05/02/2002 | WO2002010434A3 Biofilm growth device |
| 05/02/2002 | WO2002008800A3 Coupling elements for surface plasmon resonance sensors |
| 05/02/2002 | WO2002008748A3 Ion channel assay methods |
| 05/02/2002 | WO2002008253A3 A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY |
| 05/02/2002 | WO2002006460A3 Masp-2, a complement-fixing enzyme, and uses for it |
| 05/02/2002 | WO2002004914A3 Optical food oil quality sensor |
| 05/02/2002 | WO2002004523A3 Artificial antibody polypeptides |
| 05/02/2002 | WO2002003060A3 Process for the measurement of dinophysistoxin and of yessotoxin |
| 05/02/2002 | WO2001098330A3 A RECOMBINANT CELL LINE EXPRESSING GPCRx11 AS A FUNCTIONAL RECEPTOR VALIDATED BY ANGIOPEPTIN AND USEFUL FOR SCREENING OF AGONISTS AND ANTAGONISTS |
| 05/02/2002 | WO2001096368A3 Use of coiled-coil structural scaffold to generate structure-specific peptides |
| 05/02/2002 | WO2001090745A3 Determination of naaladase inhibitors |
| 05/02/2002 | WO2001090147A3 Long wavelength engineered fluorescent proteins |
| 05/02/2002 | WO2001085787A3 Stable rxr expressing cell line |
| 05/02/2002 | WO2001083555A3 Pain signaling molecules |
| 05/02/2002 | WO2001075166A3 Compositions and methods for detecting and quantifying gene expression |
| 05/02/2002 | WO2001072778A3 Method of identifying inhibitors of tie-2 |
| 05/02/2002 | WO2001070771A3 Acute neuronal induced calcium binding protein type 1 ligand |
| 05/02/2002 | WO2001069244A3 Method for labeling individual cells |
| 05/02/2002 | WO2001068824A3 Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
| 05/02/2002 | WO2001068708A3 Human and humanized fap-alpha-specific antibodies |
| 05/02/2002 | WO2001067104A3 Microstamping activated polymer surfaces |
| 05/02/2002 | WO2001067066A3 Method and apparatus for preparing cytological specimens |
| 05/02/2002 | WO2001066242A3 Device and method for performing syntheses, analyses or transport processes |
| 05/02/2002 | WO2001064741A3 Methods for selectively modulating survivin apoptosis pathways |
| 05/02/2002 | WO2001062923A3 Transporters and ion channels |
| 05/02/2002 | WO2001061008A3 Polypeptides and nucleic acids encoding same |
| 05/02/2002 | WO2001059450A3 Cells expressing zinc finger protein for drug discovery |
| 05/02/2002 | WO2001055708A3 Method of processing a sample containing at least one biological element |
| 05/02/2002 | WO2001055210A3 Human cyr61 |
| 05/02/2002 | WO2001051923A3 Screening assays using intramitochondrial calcium |
| 05/02/2002 | WO2001051635A3 Novel stra6 polypeptides |
| 05/02/2002 | WO2001048209A3 Genes identified as required for proliferation of e. coli |
| 05/02/2002 | WO2001046394A3 Mammalian protein phosphatases |
| 05/02/2002 | WO2001044813A3 Use of wicking agent to eliminate wash steps for optical diffraction-based biosensors |
| 05/02/2002 | WO2001042494A3 Test system for detecting analytes, a method for the production thereof and its use |
| 05/02/2002 | WO2001036979A3 Placental human neurokinin b precursor |
| 05/02/2002 | WO2001036475A3 Biglycan and related therapeutics and methods of use |
| 05/02/2002 | WO2001034824A3 Methods and compositions comprising renilla gfp |
| 05/02/2002 | WO2001032935A3 Molecular microarrays and methods for production and use thereof |
| 05/02/2002 | WO2001029070A3 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 05/02/2002 | WO2001027292A3 Methods and compositions for targeting a cell |
| 05/02/2002 | WO2001018172A3 Fibroblast growth factor-like polypeptides |
| 05/02/2002 | WO2001016378A3 Chromosome-wide analysis of protein-dna interactions |
| 05/02/2002 | WO2001009381A3 Methods of nucleic acid analysis by detecting molecular binding events |
| 05/02/2002 | WO2001007665A3 Sequence determination of nucleic acids using electronic detection |
| 05/02/2002 | WO2001001152A9 Method and apparatus for presenting thrombosis and hemostasis assay data |
| 05/02/2002 | WO2001000874A3 Cancer associated antigens and uses therefor |
| 05/02/2002 | WO2001000237A9 Synthetic peptide immunogens and antibodies thereto |
| 05/02/2002 | WO2000078972A3 Regulation with binding cassette transporter protein abc1 |
| 05/02/2002 | WO2000078210A9 Characteristic monitor system for use with analyte sensor |
| 05/02/2002 | WO2000077208A9 Gustatory receptors in drosophila |
| 05/02/2002 | WO2000075365A9 COMPOUNDS AND METHODS TO ENHANCE rAAV TRANSDUCTION |
| 05/02/2002 | WO2000047771A3 Biallelic markers derived from genomic regions carrying genes involved in arachidonic acid metabolism |
| 05/02/2002 | WO2000044395A9 Methods and compositions for modulating fertility |
| 05/02/2002 | WO2000042909A9 Method for diagnosing the presence and extent of halitosis activity |
| 05/02/2002 | WO1999058683A9 BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS) |
| 05/02/2002 | US20020053093 By use of biological agents which either recognize an extracellular domain of prostate specific membrane antigen or bind to and are internalized with prostate specific membrane antigen |
| 05/02/2002 | US20020053091 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof |
| 05/02/2002 | US20020052699 Paper web breakage prediction using bootstrap aggregation of classification and regression trees |
| 05/02/2002 | US20020052694 Pharmacophore fingerprinting in primary library design |
| 05/02/2002 | US20020052693 Pharmacophore models for, methods of screening for, and identification of the cytochrome P-450 inhibitory potency of neurokinin-1 receptor antagonists |